Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma

International Journal of Cancer

Volumn 125, Issue 9, 2009, Pages 2049-2057

  Volland, Sonja ^a   Kugler, Wilfried ^a   Schweigerer, Lothar ^b   Wilting, Jörg ^a   Becker, Jürgen ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Deutsche Akademie fur Kinder und Jugendmedizin e V   (Germany)

Author keywords

Apoptosis; Hemorrhage; Invasion; Metastasis; MYCN

Indexed keywords

GELATINASE A; HYPOCALCIN; STANNIOCALCIN 2; UNCLASSIFIED DRUG; GLYCOPROTEIN; MESSENGER RNA; SIGNAL PEPTIDE; STC2 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BLEEDING; BLOOD VESSEL; CANCER INVASION; CANCER STAGING; CELL MIGRATION; CELL PROLIFERATION; CHORIOALLANTOIS; CLINICAL ARTICLE; CONTROLLED STUDY; GRANULATION TISSUE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; NEUROBLASTOMA; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SOLID TUMOR; ANIMAL; CHICK EMBRYO; GENETICS; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CHICK EMBRYO; GLYCOPROTEINS; GRANULATION TISSUE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASM INVASIVENESS; NEUROBLASTOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 70249090440     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24564     Document Type: Article

References (27)

1. Wagner GF, DiMattia GE. The stanniocalcin family of proteins. J Exp Zool 2006;305A:769-780
2. Chang AC, Reddel RR. Identification of a second stanniocalcin cDNA in mouse and human: stanniocalcin 2. Mol Cell Endocrinol 1998;141:95-99 (Pubitemid 28393383)
3. DiMattia GE, Varghese R, Wagner GF. Molecular cloning and characterization of stanniocalcin-related protein. Mol Cell Endocrinol 1998;146:137-140 (Pubitemid 29003288)
4. Ishibashi K, Miyamoto K, Taketani Y, Morita K, Takeda E, Sasaki S, Imai M. Molecular cloning of a second human stanniocalcin homologue (STC2). Biochem Biophys Res Commun 1998;250:252-258 (Pubitemid 28463864)
5. McCudden CR, James KA, Hasilo C, Wagner GF. Characterization of mammalian stanniocalcin receptors. Mitochondrial targeting of ligand and receptor for regulation of cellular metabolism. J Biol Chem 2002;277:45249-45258 (Pubitemid 36159130)
6. Moore EE, Kuestner RE, Conklin DC, Whitmore TE, Downey W, Buddle MM, Adams RL, Bell LA, Thompson DL, Wolf A, Chen L, Stamm MR, et al. Stanniocalcin 2: characterization of the protein and its localization to human pancreatic alpha cells. HormMetab Res 1999;31:406-414 (Pubitemid 29352613)
7. Honda S, Kashiwagi M, Ookata K, Tojo A, Hirose S. Regulation by 1alpha,25-dihydroxyvitamin D(3) of expression of stanniocalcin messages in the rat kidney and ovary. FEBS Lett 1999;459:119-122
8. Wong CK, Yeung HY, Mak NK, DiMattia GE, Chan DK, Wagner GF. Effects of dibutyryl cAMP on stanniocalcin and stanniocalcin-related protein mRNA expression in neuroblastoma cells. J Endocrinol 2002;173:199-209.
9. Jellinek DA, Chang AC, Larsen MR, Wang X, Robinson PJ, Reddel RR. Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells. Biochem J 2000;350 (Part 2): 453-461 (Pubitemid 30708413)
10. Bouras T, Southey MC, Chang AC, Reddel RR, Willhite D, Glynne R, Henderson MA, Armes JE, Venter DJ. Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res 2002;62:1289-1295 (Pubitemid 34407780)
11. Meyer HA, Tolle A, Jung M, Fritzsche FR, Haendler B, Kristiansen I, Gaspert A, Johannsen M, Jung K, Kristiansen G. Identification of Stanniocalcin 2 as Prognostic Marker in Renal Cell Carcinoma. Eur Urol 2009;55:669-678
12. Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet 2007;369:2106-2120
13. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Kemshead J. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11:1466-1477 (Pubitemid 23228250)
14. Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D'Angio G, De Bernardi B, Evans AE, Favrot M, Freeman AI, Haase G, Hartmann O. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 1988;6:1874-1881 (Pubitemid 19089071)
15. Westermann F, Schwab M. Genetic parameters of neuroblastomas. Cancer Lett 2002;184:127-147
16. Becker J, Erdlenbruch B, Noskova I, Schramm A, Aumailley M, Schorderet DF, Schweigerer L. Keratoepithelin suppresses the progression of experimental human neuroblastomas. Cancer Res 2006; 66:5314-5321 (Pubitemid 43844956)
17. Becker J, Volland S, Noskova I, Schramm A, Schweigerer LL, Wilting J. Keratoepithelin reverts the suppression of tissue factor pathway inhibitor 2 by MYCN in human neuroblastoma: a mechanism to inhibit invasion. Int J Oncol 2008;32:235-240 (Pubitemid 351176082)
18. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-279
19. Fox MH. A model for the computer analysis of synchronous DNA distributions obtained by flow cytometry. Cytometry 1980;1:71-77
20. Papoutsi M, Siemeister G, Weindel K, Tomarev SI, Kurz H, Schachtele C, Martiny-Baron G, Christ B, Marme D, Wilting J. Active interaction of human A375 melanoma cells with the lymphatics in vivo. Histochem Cell Biol 2000;114:373-385
21. Hagedorn M, Balke M, Schmidt A, Bloch W, Kurz H, Javerzat S, Rousseau B, Wilting J, Bikfalvi A. VEGF coordinates interaction of pericytes and endothelial cells during vasculogenesis and experimental angiogenesis. Dev Dyn 2004;230:23-33. (Pubitemid 38544070)
22. Castleberry RP. Neuroblastoma. Eur J Cancer 1997;33:1430-7; discussion 7-8.
23. Raulic S, Ramos-Valdes Y, DiMattia GE. Stanniocalcin 2 expression is regulated by hormone signaling and negatively affects breast cancer cell viability in vitro. J Endocrinol 2008;197:517-529 (Pubitemid 351803956)
24. Gagliardi AD, Kuo EY, Raulic S, Wagner GF, DiMattia GE. Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs. Am J Physiol Endocrinol Metab 2005;288:E92-E105. (Pubitemid 40023795)
25. Xiao LJ, Yuan JX, Song XX, Li YC, Hu ZY, Liu YX. Expression and regulation of stanniocalcin 1 and 2 in rat uterus during embryo implantation and decidualization. Reproduction 2006;131: 1137-1149 (Pubitemid 43904987)
26. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315: 1650-1659
27. Chang AC-M, Hook J, Lemckert FA, McDonald MM, Nguyen M-AT, Hardeman EC, Little DG, Gunning PW, Reddel RR. The murine stanniocalcin 2 gene is a negative regulator of postnatal growth. Endocrinology 2008;145:2403-2410 (Pubitemid 351574495)